Published Date: 14 Mar 2023
The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.
Read Full NewsBritish lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...
In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.
Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.
Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.
In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.
For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.
1.
The White House has postponed its plan to outlaw menthol cigarettes indefinitely.
2.
Glioblastoma treatment breakthrough shows promise
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
5.
A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.
1.
Molecular Classification of Treatment-Refractory Anemia
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Immune Regulation of Blood Cell Development
4.
Clinical Guidelines for Monitoring Bone Marrow Functional Reserve
5.
Preventing Functional Iron Deficiency in High-Risk Populations
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation